Mental Disorders Lead Global Disability
Analysis based on 23 articles · First reported May 21, 2026 · Last updated Jun 02, 2026
The study's findings indicate a significant and growing global health crisis, which could lead to increased demand for mental healthcare services and related pharmaceutical products. This may impact healthcare providers, insurance companies, and pharmaceutical firms, potentially driving investment in mental health solutions and preventative measures.
A comprehensive study, the Global Burden of Disease 2023, led by the Institute for Health Metrics and Evaluation>>>, the Queensland University of Technology, and the Queensland Centre for Mental Health Research, and published in The Lancet, reveals that mental disorders have become the leading cause of disability worldwide, surpassing cardiovascular disease and cancer. The study found that nearly 1.2 billion people globally were living with a mental health condition in 2023, almost double the number in 1990. Anxiety and major depressive disorders are the primary drivers of this surge, with cases increasing by 47% and 24% respectively since 2019, peaking after the COVID-19 pandemic. The burden disproportionately affects individuals aged 15-19 and women. Damian Santomauro>>>, lead author, emphasized the urgent need for sustained investment in mental health systems and expanded access to care. Ferrari>>>, a co-author, highlighted that the global response to mental disorders is currently insufficient. Factors contributing to this trend include social isolation, economic insecurity, child maltreatment, domestic violence, genetics, rising inequality, climate change, pandemics, and conflict. The Gates Foundation>>> provided funding for this extensive research.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard